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Abstract Article Info 
Introduction: The most common complaint in almost half of nasopharyngeal carcinoma (NPC) patients is a 
lump in the neck. Neurological symptoms occur less frequently, whereas blindness occurs in only less than one 
percent of cases.  
Case Report: A 47-year-old male had complained about headache, nasal voice, and blindness in the right eye 
since a month ago. An examination found a mass in the right nasal cavity, right neck lymph nodes enlargement, 
damage to the right oculomotor (III), trochlear (IV), and abducens (VI) nerve, and right optic nerve (II). On 
funduscopy, the right macular reflex decreased. On CT scan there was a right nasopharyngeal mass extending 
to intracranial and right intraorbital spaces.  
Conclusion: There was a direct infiltration of NPC into surrounding and intracranial structures. Unilateral 
blindness might be caused by expansion to middle cerebral fossa and orbita. It could also be caused by optic 
nerve compression from surrounding tumor tissue.. 
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1. CASE REPORT 
Nasopharyngeal carcinoma (NPC) is a type of carcinoma originating 
from the epithelium or mucosa and crypts that overlay the nasopharyngeal 
surface. Nasopharyngeal carcinoma (NPC) is a malignancy that is rare in 
most parts of the world and one of the most puzzling, often misdiagnosed, 
and difficult to understand. The incidence of NPC is low in many countries 
and North America, as well as Japan and India, at less than 1 per 100,000 
people, but high in South China, Hong Kong, Alaska, and Greenland. The 
pattern of incidence shows that the prevalence of NPC is higher in Chinese 
natives wherever they migrate. In Southeastern Asia the overall incidence is 
6.5/100,000 person-years in male and 2,6/100.000 person-years in female 
population. In Indonesia, NPC is the fifth largest cancer, around 5.78% of 
all cancers with an incidence of 6.2/100,000 population per year. The NPC 
in recent decades has attracted the world's attention because of the complex 
interactions between genetics, viruses, environmental factors, and food, 
which may be related to the etiology of the disease. The most common 
complaint is a lump in the neck in more than half of the patients. Headache 
occurs in more than one-third of patients. Cranial nerve disorders are usually 
found at an advanced stage, while visual impairment only occurs in two 
percent of patients [1-7]. 
A 47-year-old man, a Sumatran tribe, came to the Emergency Unit 
(UGD) of RSUD Mohammad Hoesin Palembang with the main complaint 
of right-sided headache for one month before being admitted to the hospital. 
An intermittent throbbing headache that got worse over time. The 
medication may help temporarily, only to come back later in a few hours. 
The patient indicated of a lump on the right neck since 6 months ago and 
loss of appetite. He was also losing his right vision one month prior to 
admission; started with a frequent double vision which later on became more 
blurred, it eventually was only able to recognize the coming direction of the 
light. According to the patient, he ate salted fish almost every day. 
On general physical examination, it was found awareness status of compost 
mentis (E4V5M6), adequate nutritional status, blood pressure 120/70 mmHg, 
pulse 82 x/minute regularly, breathing 22 x/minute and axillary temperature 36,8 
°C. The eyes were proptosis, not anemic, not jaundice. From ENT examination 
findings obtained from endoscopic examination are a mass particularly in the 
right nose, enlarged lymph nodes on the right neck level II, III, IV, and V, with a 
size of 6x7x4 cm, well-defined, bobbing and hard on palpation. It also found 
enlargement of the lymph nodes in the left neck level I, and II, with a size of 
2x3x2 cm, well-defined and hard on palpation. On a neurological examination, 
awareness of compost mentis was obtained and no sign of brain membrane 
excitability was found. Eye examination: anisocoric pupils, 5 mm/3 mm diameter 
for direct and indirect negative light reflexes. Funduscopy of the right eye showed 
the well-defined papillary nerve II, cupping disc ratio 0.3, arterial/venous: 2/3, 
ex-macular reflex decreased, the retina was intact. There were right cranial nerves 
II, III, IV, and VI lesions. Normal motoric and physiological reflexes. A 
pathological reflex was not found. The sensory was normal. Hematological 
laboratory examination: mild anemia (RBC: 4.37x106/μl, HGB: 11.8 g/ dL, 
HCT: 37.6%). Blood chemistry examination: liver function, kidney function, 
electrolytes, and fat levels within normal limits, blood sugar level was 112 mg/L. 
Chest X-ray and ECG within normal limits. Coronal slices of the nasopharynx 
CT scan with contrast showed right-left nasopharyngeal mass extending to the 
left oropharyngeal parapharyngeal space of the nasal cavity, right ethmoid sinus 
and right maxillary sphenoid. Sphenoid/infiltration base destruction was 

























Picture 2. Nasopharyngeal CT Scan with coronal cut contrast 







From the nasopharyngeal histopathology examination, a tissue 
preparation coated with squamous epithelium which partially dysplastic 
was found. Stromal tissue appeared on the subepithelium consisting of the 
invasive anaplastic proliferative epithelial cells, with an ovoid round 
nucleus, pleomorphic, irregular core membrane, partially with a 
prominent nucleus, narrow cytoplasm, indistinct border (syncytial), and 
also spindle, hyperchromatic cysts; nucleolus was not clear. These cells 
appeared to form a solid arrangement. Around them appeared a little 
necrosis and lymphocyte and PMN inflammatory cells and erythrocytes 
infiltration. Mitosis was difficult to find. Impression: undifferentiated 
non-keratinizing squamous cell carcinoma. The patient was scheduled for 
radiotherapy and chemotherapy. 
2. DISCUSSION 
This case described a male patient with nasopharyngeal carcinoma 
(NPC). NPC can occur at any age, however, it was found very rarely in 
patients under the age of  20 years and mostly in people between 45-54 
years. Nasopharyngeal carcinoma is more common in men than in women 
with a ratio between 2-3:1. Based on the medical records in RSUP. Dr. Moh 
Hoesin Palembang, from January 2013 to July 2017, there were 284 cases 
of nasopharyngeal carcinoma. In the oncology division of the ENT 
department of RSMH nasopharyngeal carcinoma was the most commonly 
seen disease in the visiting patients.  
 
Picture 3. Nasopharyngeal Histopathology 
Although NPC can be found at all ages, rarely under 20 years, 
almost a quarter of patients are under thirty years old. The incidence of 
NPC starts to increase at the age of 20-24 years, reaches plateau 
between the ages of 45-54 years, then decreases. About 80% of NPC is 
found in productive age (30-59 years) and reaches its peak between 40-
49 years old [2, 8]. 
Nasopharyngeal carcinoma (NPC) is a unique head-neck 
malignancy. Nasopharyngeal carcinoma is rarely reported in Western 
countries, relatively small numbers in North America, but highly 
frequent in South China, Hong Kong, Taiwan, Singapore, and 
Malaysia, which is the most common malignancy in Cantonese. The 
incidence pattern shows a higher prevalence of NPC in Chineses 
wherever they migrate. In Indonesia, NPC is the fifth largest cancer, 
around 5.78% of all cancers, with an incidence of 6.2/100,000 
population per year. Consumption of preserved food including salted 
fish has been implicated in its etiology in earlier studies. Its 
contribution to pathogenesis of NPC remains to be determined. A 
decreasing trend of NPC incidence was observed in Hong Kong, 
Taiwan and Singapore in recent years which may be accounted by a 
change of dietary habits. [1, 2, 3, 5, 13].  
NPC usually originates from the lateral wall of the nasopharynx, 
including the Rosenmuller fossa. Then it can expand into or out of the 
nasopharynx to the other lateral wall and/or posterosuperior to the 
basilar skull or base of palate, nasal cavity or oropharynx. It generally 
metastasizes to cervical lymph nodes. Distant metastasis can be to the 
bones, lungs, mediastinum and less frequently, to the liver. Cervical 
lymphadenopathy is the initial symptom in many patients, and the 
diagnosis of NPC is often obtained from lymph node biopsy. Symptoms 
related to primary tumors include trismus, pain, otitis media, nasal 
regurgitation due to soft palate paresis, hearing loss and cranial nerve 
paralysis. Further growth can cause nasal obstruction or bleeding and 
discharge. Metastasis can cause bone pain and organ dysfunction, 
hence, osteoarthropathy as a paraneoplastic syndrome [7, 9].  
Cranial nerve involvement was found in 22% of NPC patients at the 
initial examination. Cranial neuropathy occurs when the skull base is 
invaded by the tumor. NPC tends to spread and infiltrate the 
surrounding tissue and might spread superiorly involving the skull and 
intracranial base, and the cranial nerves. The incidence of invasion of 
the cranial base and brain is 12-31%. The invasion can also be anteriorly 
through the nasal cavity, paranasal sinuses, pterygopalatine fossa, and 
orbital apex. Patients with cranial nerve involvement may show ocular 
or orbital symptoms, such as diplopia, proptosis, and limitations of 
extraocular motion [7, 10]. 
NPC with orbital invasion is rarely reported at around 0-3%. 
Sympathetic innervation of the eye which ciliospinal center, is located 
in the lateral horn of the spinal cord from C8 to T2.  Ocular and/or 
orbital manifestations of NPC include ocular motility disorders, blurred 
vision, proptosis, orbital pain, and optic disc edema. In most cases, 
patients experience nasal or aural symptoms at first. Most severe visual 
impairments occur due to tumor compression on the optic nerve. Optical 
atrophy usually occurs in the late stages of the disease with the symptom 
of severe visual acuity. NPC involving pterygopalatine and 
infratemporal fossa can directly affect the orbit through inferior orbital. 
The invasion of the orbit can be in several ways. The pterygopalatine 
and inferior orbital surges are the most common routes of invasion, 
followed by an invasion of the paranasal sinuses. The inferior orbital 
fissures form a direct communication of the orbits and infratemporal 
fossa. The most posterior part also meets the pterygopalatine fossa, 
which forms direct communication between the pterygopalatine fossa 
and the orbital apex. Tumors in the ethmoid and/or sphenoid sinuses 
might erode the thin lamina papyrias to reach the medial orbit and 
retrobulbar region, this pathway is the second most frequent pathway to 
the orbit. NPC rarely involves the maxillary sinus which then invades 
the orbital base. Orbital involvement worsens the prognosis. In stage T4 
NPC, intracranial extension/cranial nerve paralysis and involvement of 
the orbit causes a relatively worse prognosis than the involvement of 
infratemporal or hypopharyngeal fossa. [7, 8, 10, 16 ]. 
Headache in NPC patients is generally associated with cranial base 
invasion, intracranial metastasis or craniaal osteoradionecrosis, as that 
is found in these patients. NPC is histopathologically divided into three 
categories: keratinizing squamous cell carcinoma (WHO type I), 
nonkeratinizing squamous cell carcinoma (WHO type II), and 
undifferentiated carcinoma (WHO type III). This patient was diagnosed 
with WHO type III NPC, the most common form in Southeast Asia, 
including Indonesia and other areas of high incidence [8, 12].  
Radiotherapy has been a standard of NPC therapy for a long time 
because of its anatomical location and is relatively radiosensitive, but 
the failure rate is high in patients who experience metastasis. The 
treatment of stage I NPC is radiotherapy alone. The combination of 
chemotherapy with radiotherapy has been widely accepted as a 
treatment modality for advanced NPC, but it is still not optimal. The 5-
year life expectancy in stages I, II, III, and IV tumors is 95-70%, 83-
65%, 76-54%, and 56-29% [2, 15]. 
3. CONCLUSION 
The case of nasopharyngeal carcinoma has been reported with 
papiledema and right cranial nerve II, III, IV, VI lesions. Head CT scan 
with axial and coronal slices without and with contrast showed a right 
nasopharyngeal mass extending to the right etmoidal sinus and sfenoidalis 
accompanied by right sphenoid erosion and intracranial metastases and 
cerebral edema. From the nasopharyngeal biopsy, the impression is 
undifferentiated carcinoma. This patient is planned to undergo 
radiotherapy and chemotherapy. 
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